

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of digestive system process (GO:0060456) | 7.26949825 |
| 2 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 5.99045309 |
| 3 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 5.99045309 |
| 4 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 5.43144838 |
| 5 | cellular response to ATP (GO:0071318) | 4.94582666 |
| 6 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.83349860 |
| 7 | sphingosine metabolic process (GO:0006670) | 4.74674631 |
| 8 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.71043337 |
| 9 | opioid receptor signaling pathway (GO:0038003) | 4.59986821 |
| 10 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.55153897 |
| 11 | flavonoid metabolic process (GO:0009812) | 4.32582381 |
| 12 | diol metabolic process (GO:0034311) | 4.21303111 |
| 13 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.20014224 |
| 14 | behavioral response to nicotine (GO:0035095) | 4.15633974 |
| 15 | response to histamine (GO:0034776) | 4.12481456 |
| 16 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.11406396 |
| 17 | negative regulation of cAMP-mediated signaling (GO:0043951) | 4.10910964 |
| 18 | protein localization to synapse (GO:0035418) | 3.98893255 |
| 19 | adaptation of signaling pathway (GO:0023058) | 3.98139138 |
| 20 | sphingoid metabolic process (GO:0046519) | 3.94953451 |
| 21 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 3.92286944 |
| 22 | adult feeding behavior (GO:0008343) | 3.88325341 |
| 23 | detection of light stimulus involved in visual perception (GO:0050908) | 3.83788818 |
| 24 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.83788818 |
| 25 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.81578184 |
| 26 | hindbrain development (GO:0030902) | 3.80029173 |
| 27 | cellular response to ammonium ion (GO:0071242) | 3.79768414 |
| 28 | cochlea development (GO:0090102) | 3.71561897 |
| 29 | cell differentiation involved in metanephros development (GO:0072202) | 3.67189228 |
| 30 | behavioral response to ethanol (GO:0048149) | 3.65558260 |
| 31 | piRNA metabolic process (GO:0034587) | 3.65485700 |
| 32 | serotonin metabolic process (GO:0042428) | 3.55821465 |
| 33 | regulation of protein glycosylation (GO:0060049) | 3.54248673 |
| 34 | regulation of cAMP-mediated signaling (GO:0043949) | 3.44450479 |
| 35 | adrenergic receptor signaling pathway (GO:0071875) | 3.40640129 |
| 36 | protein-chromophore linkage (GO:0018298) | 3.39155328 |
| 37 | inner ear receptor cell development (GO:0060119) | 3.37381551 |
| 38 | response to pheromone (GO:0019236) | 3.37307201 |
| 39 | DNA methylation involved in gamete generation (GO:0043046) | 3.35467000 |
| 40 | uterus development (GO:0060065) | 3.33143627 |
| 41 | primary amino compound metabolic process (GO:1901160) | 3.31505621 |
| 42 | postsynaptic membrane organization (GO:0001941) | 3.30780266 |
| 43 | positive regulation of glomerulus development (GO:0090193) | 3.27661320 |
| 44 | coenzyme catabolic process (GO:0009109) | 3.22789905 |
| 45 | regulation of translational termination (GO:0006449) | 3.18226592 |
| 46 | auditory receptor cell stereocilium organization (GO:0060088) | 3.17195102 |
| 47 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.17128724 |
| 48 | regulation of digestive system process (GO:0044058) | 3.16352720 |
| 49 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.10652478 |
| 50 | mesenchymal to epithelial transition (GO:0060231) | 3.09891412 |
| 51 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.09031102 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 3.05740506 |
| 53 | regulation of acrosome reaction (GO:0060046) | 3.01012104 |
| 54 | rhodopsin mediated signaling pathway (GO:0016056) | 3.00931165 |
| 55 | positive regulation of fatty acid oxidation (GO:0046321) | 3.00168715 |
| 56 | inner ear receptor stereocilium organization (GO:0060122) | 3.00076595 |
| 57 | neuronal action potential (GO:0019228) | 2.99558010 |
| 58 | neuronal action potential propagation (GO:0019227) | 2.98351223 |
| 59 | innervation (GO:0060384) | 2.97420663 |
| 60 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.94984098 |
| 61 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.94882900 |
| 62 | cornea development in camera-type eye (GO:0061303) | 2.93211291 |
| 63 | cellular response to alkaloid (GO:0071312) | 2.89070716 |
| 64 | protein K6-linked ubiquitination (GO:0085020) | 2.88829402 |
| 65 | metanephric mesenchyme development (GO:0072075) | 2.88311392 |
| 66 | cAMP catabolic process (GO:0006198) | 2.86798917 |
| 67 | proline transport (GO:0015824) | 2.85287244 |
| 68 | metanephric tubule development (GO:0072170) | 2.84901369 |
| 69 | metanephric nephron tubule development (GO:0072234) | 2.84901369 |
| 70 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.84463642 |
| 71 | axonemal dynein complex assembly (GO:0070286) | 2.80762665 |
| 72 | ether lipid metabolic process (GO:0046485) | 2.79968604 |
| 73 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.76690650 |
| 74 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.76684098 |
| 75 | sperm capacitation (GO:0048240) | 2.74423547 |
| 76 | regulation of germinal center formation (GO:0002634) | 2.73114165 |
| 77 | L-methionine salvage (GO:0071267) | 2.69685894 |
| 78 | L-methionine biosynthetic process (GO:0071265) | 2.69685894 |
| 79 | amino acid salvage (GO:0043102) | 2.69685894 |
| 80 | membrane depolarization during action potential (GO:0086010) | 2.69366795 |
| 81 | negative regulation of macrophage differentiation (GO:0045650) | 2.69232514 |
| 82 | indole-containing compound metabolic process (GO:0042430) | 2.68748228 |
| 83 | NAD biosynthetic process (GO:0009435) | 2.67753271 |
| 84 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.64748895 |
| 85 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.64748895 |
| 86 | T-helper cell differentiation (GO:0042093) | 2.63829588 |
| 87 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.63829588 |
| 88 | cyclic nucleotide catabolic process (GO:0009214) | 2.61007233 |
| 89 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.57825772 |
| 90 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.56489072 |
| 91 | negative regulation of multicellular organism growth (GO:0040015) | 2.54327806 |
| 92 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.52780194 |
| 93 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.52771234 |
| 94 | metanephric nephron epithelium development (GO:0072243) | 2.50048246 |
| 95 | startle response (GO:0001964) | 2.49297039 |
| 96 | phenylpropanoid metabolic process (GO:0009698) | 2.48786946 |
| 97 | glycerophospholipid catabolic process (GO:0046475) | 2.48431089 |
| 98 | chemosensory behavior (GO:0007635) | 2.47851824 |
| 99 | metanephric epithelium development (GO:0072207) | 2.47369294 |
| 100 | tachykinin receptor signaling pathway (GO:0007217) | 10.2308064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.54514574 |
| 2 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.96752227 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.89669479 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.88410137 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 2.87796210 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.81480535 |
| 7 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.75514652 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.30182101 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.21197854 |
| 10 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.06907423 |
| 11 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.01631981 |
| 12 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.00947944 |
| 13 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.93325070 |
| 14 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84273861 |
| 15 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81885023 |
| 16 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.77581525 |
| 17 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.77581525 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.74629147 |
| 19 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72871091 |
| 20 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.72096525 |
| 21 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.66472273 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.66181852 |
| 23 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.65780513 |
| 24 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.65458806 |
| 25 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65458806 |
| 26 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.65220905 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.63098768 |
| 28 | TCF4_23295773_ChIP-Seq_U87_Human | 1.59860096 |
| 29 | STAT3_23295773_ChIP-Seq_U87_Human | 1.57187163 |
| 30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.56746049 |
| 31 | RXR_22108803_ChIP-Seq_LS180_Human | 1.54493197 |
| 32 | P300_19829295_ChIP-Seq_ESCs_Human | 1.53073797 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.49197585 |
| 34 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.48620214 |
| 35 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.44626207 |
| 36 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43453539 |
| 37 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.43298731 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39739614 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39400045 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36697958 |
| 41 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.36217465 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36112047 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35574322 |
| 44 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.31140405 |
| 45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.30332351 |
| 46 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.29793974 |
| 47 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29209584 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28838278 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27145037 |
| 50 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27046852 |
| 51 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26148389 |
| 52 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25462876 |
| 53 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.25425097 |
| 54 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24793047 |
| 55 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21338901 |
| 56 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.21028095 |
| 57 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.21028095 |
| 58 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.19765977 |
| 59 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19384621 |
| 60 | KDM2B_26808549_Chip-Seq_REH_Human | 1.19230925 |
| 61 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17562350 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17037671 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15300160 |
| 64 | NCOR_22424771_ChIP-Seq_293T_Human | 1.15264496 |
| 65 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15118971 |
| 66 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14205906 |
| 67 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14107444 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13929462 |
| 69 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13149891 |
| 70 | ERA_21632823_ChIP-Seq_H3396_Human | 1.13035880 |
| 71 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.12418553 |
| 72 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.12221953 |
| 73 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.12211944 |
| 74 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.11930789 |
| 75 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11847340 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11617591 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10290679 |
| 78 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.08021171 |
| 79 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.07173606 |
| 80 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07066052 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.06969947 |
| 82 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06337917 |
| 83 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05885503 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05554633 |
| 85 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04638293 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03582480 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02575264 |
| 88 | EWS_26573619_Chip-Seq_HEK293_Human | 1.02367328 |
| 89 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02246627 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01694139 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01600642 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00598837 |
| 93 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99932716 |
| 94 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99222088 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98454217 |
| 96 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.97846145 |
| 97 | AR_19668381_ChIP-Seq_PC3_Human | 0.96973139 |
| 98 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.96374559 |
| 99 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95936853 |
| 100 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95646341 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 4.80790019 |
| 2 | MP0001968_abnormal_touch/_nociception | 3.36425413 |
| 3 | MP0001501_abnormal_sleep_pattern | 3.04493426 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.99974794 |
| 5 | MP0005646_abnormal_pituitary_gland | 2.87256617 |
| 6 | MP0002638_abnormal_pupillary_reflex | 2.78526874 |
| 7 | MP0005551_abnormal_eye_electrophysiolog | 2.63699349 |
| 8 | MP0005360_urolithiasis | 2.49633827 |
| 9 | MP0002735_abnormal_chemical_nociception | 2.37772284 |
| 10 | MP0003646_muscle_fatigue | 2.31829576 |
| 11 | MP0002876_abnormal_thyroid_physiology | 2.18581003 |
| 12 | MP0005171_absent_coat_pigmentation | 2.16630950 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.15647359 |
| 14 | MP0001324_abnormal_eye_pigmentation | 2.00805141 |
| 15 | MP0001664_abnormal_digestion | 1.97778952 |
| 16 | MP0008872_abnormal_physiological_respon | 1.97672879 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 1.94681951 |
| 18 | MP0000372_irregular_coat_pigmentation | 1.94344333 |
| 19 | MP0004381_abnormal_hair_follicle | 1.92477844 |
| 20 | MP0005075_abnormal_melanosome_morpholog | 1.87132379 |
| 21 | MP0002733_abnormal_thermal_nociception | 1.85991642 |
| 22 | MP0006276_abnormal_autonomic_nervous | 1.85836573 |
| 23 | MP0003136_yellow_coat_color | 1.84840512 |
| 24 | MP0002272_abnormal_nervous_system | 1.84539035 |
| 25 | MP0000015_abnormal_ear_pigmentation | 1.79728519 |
| 26 | MP0009745_abnormal_behavioral_response | 1.77446302 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.76377066 |
| 28 | MP0009046_muscle_twitch | 1.66113292 |
| 29 | MP0004742_abnormal_vestibular_system | 1.64108212 |
| 30 | MP0003879_abnormal_hair_cell | 1.62026959 |
| 31 | MP0001970_abnormal_pain_threshold | 1.59914319 |
| 32 | MP0005670_abnormal_white_adipose | 1.55949994 |
| 33 | MP0003868_abnormal_feces_composition | 1.54985498 |
| 34 | MP0003635_abnormal_synaptic_transmissio | 1.52487526 |
| 35 | MP0002557_abnormal_social/conspecific_i | 1.39120106 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.38435140 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.36652124 |
| 38 | MP0001486_abnormal_startle_reflex | 1.35266889 |
| 39 | MP0003943_abnormal_hepatobiliary_system | 1.34665944 |
| 40 | MP0002837_dystrophic_cardiac_calcinosis | 1.32792287 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.32443898 |
| 42 | MP0002090_abnormal_vision | 1.31039120 |
| 43 | MP0002229_neurodegeneration | 1.30436520 |
| 44 | MP0005645_abnormal_hypothalamus_physiol | 1.30147370 |
| 45 | MP0005389_reproductive_system_phenotype | 1.29889686 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.29222676 |
| 47 | MP0004270_analgesia | 1.27123238 |
| 48 | MP0005187_abnormal_penis_morphology | 1.24848950 |
| 49 | MP0005220_abnormal_exocrine_pancreas | 1.24084188 |
| 50 | MP0004043_abnormal_pH_regulation | 1.23578362 |
| 51 | MP0001919_abnormal_reproductive_system | 1.22925996 |
| 52 | MP0001963_abnormal_hearing_physiology | 1.22610889 |
| 53 | MP0009840_abnormal_foam_cell | 1.21086332 |
| 54 | MP0000427_abnormal_hair_cycle | 1.19280813 |
| 55 | MP0010386_abnormal_urinary_bladder | 1.18594020 |
| 56 | MP0004133_heterotaxia | 1.18324523 |
| 57 | MP0002067_abnormal_sensory_capabilities | 1.17490899 |
| 58 | MP0003718_maternal_effect | 1.17402794 |
| 59 | MP0000534_abnormal_ureter_morphology | 1.17216635 |
| 60 | MP0002751_abnormal_autonomic_nervous | 1.17110829 |
| 61 | MP0005253_abnormal_eye_physiology | 1.14567636 |
| 62 | MP0003942_abnormal_urinary_system | 1.13421312 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.11964654 |
| 64 | MP0000026_abnormal_inner_ear | 1.11745793 |
| 65 | MP0002160_abnormal_reproductive_system | 1.11445140 |
| 66 | MP0002063_abnormal_learning/memory/cond | 1.08847275 |
| 67 | MP0003866_abnormal_defecation | 1.07949361 |
| 68 | MP0002064_seizures | 1.06069475 |
| 69 | MP0003633_abnormal_nervous_system | 1.03673817 |
| 70 | MP0003315_abnormal_perineum_morphology | 1.02407187 |
| 71 | MP0002184_abnormal_innervation | 1.02401923 |
| 72 | MP0000678_abnormal_parathyroid_gland | 1.01818669 |
| 73 | MP0002572_abnormal_emotion/affect_behav | 1.01320774 |
| 74 | MP0004484_altered_response_of | 0.99511010 |
| 75 | MP0010329_abnormal_lipoprotein_level | 0.99320231 |
| 76 | MP0002168_other_aberrant_phenotype | 0.98545459 |
| 77 | MP0003938_abnormal_ear_development | 0.97580403 |
| 78 | MP0005647_abnormal_sex_gland | 0.94409249 |
| 79 | MP0004885_abnormal_endolymph | 0.93315285 |
| 80 | MP0005395_other_phenotype | 0.92309142 |
| 81 | MP0003045_fibrosis | 0.91634846 |
| 82 | MP0002693_abnormal_pancreas_physiology | 0.89895903 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.89773702 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 0.87063841 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.86829655 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.85856430 |
| 87 | MP0001666_abnormal_nutrient_absorption | 0.85060313 |
| 88 | MP0004142_abnormal_muscle_tone | 0.84288556 |
| 89 | MP0002938_white_spotting | 0.84111596 |
| 90 | MP0000604_amyloidosis | 0.80382519 |
| 91 | MP0005310_abnormal_salivary_gland | 0.79934723 |
| 92 | MP0001661_extended_life_span | 0.78851617 |
| 93 | MP0009764_decreased_sensitivity_to | 0.77442519 |
| 94 | MP0005334_abnormal_fat_pad | 0.77033029 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.76906674 |
| 96 | MP0005195_abnormal_posterior_eye | 0.76024911 |
| 97 | MP0002095_abnormal_skin_pigmentation | 0.75191530 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.74492307 |
| 99 | MP0004924_abnormal_behavior | 0.74492307 |
| 100 | MP0003631_nervous_system_phenotype | 0.73382747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macular pigmentation (HP:0008002) | 6.94001570 |
| 2 | Congenital stationary night blindness (HP:0007642) | 4.37221708 |
| 3 | Thyroid-stimulating hormone excess (HP:0002925) | 4.25327892 |
| 4 | Parakeratosis (HP:0001036) | 4.12565426 |
| 5 | Focal motor seizures (HP:0011153) | 3.81293328 |
| 6 | Decreased central vision (HP:0007663) | 3.73169932 |
| 7 | Congenital sensorineural hearing impairment (HP:0008527) | 3.70601931 |
| 8 | Chronic otitis media (HP:0000389) | 3.63651768 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 3.62282843 |
| 10 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.37594307 |
| 11 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.37594307 |
| 12 | Acanthocytosis (HP:0001927) | 3.30773107 |
| 13 | Recurrent sinusitis (HP:0011108) | 3.19876604 |
| 14 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.19112285 |
| 15 | Hypomagnesemia (HP:0002917) | 3.18202182 |
| 16 | Broad-based gait (HP:0002136) | 3.14487749 |
| 17 | Dialeptic seizures (HP:0011146) | 3.13713617 |
| 18 | Volvulus (HP:0002580) | 2.91750744 |
| 19 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.79330157 |
| 20 | Osteomalacia (HP:0002749) | 2.78777263 |
| 21 | Focal seizures (HP:0007359) | 2.74691740 |
| 22 | Episodic fever (HP:0001954) | 2.72670694 |
| 23 | Severe visual impairment (HP:0001141) | 2.72585669 |
| 24 | Chronic sinusitis (HP:0011109) | 2.68201561 |
| 25 | Progressive inability to walk (HP:0002505) | 2.64564944 |
| 26 | Hypoplasia of the fovea (HP:0007750) | 2.64518234 |
| 27 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.64518234 |
| 28 | Oligodontia (HP:0000677) | 2.62149203 |
| 29 | Pendular nystagmus (HP:0012043) | 2.61335455 |
| 30 | Hypophosphatemic rickets (HP:0004912) | 2.61092283 |
| 31 | Hyperventilation (HP:0002883) | 2.60935810 |
| 32 | Central scotoma (HP:0000603) | 2.55290583 |
| 33 | Amelogenesis imperfecta (HP:0000705) | 2.55226351 |
| 34 | Intestinal atresia (HP:0011100) | 2.54622179 |
| 35 | Choroideremia (HP:0001139) | 2.53818437 |
| 36 | Macular degeneration (HP:0000608) | 2.52212127 |
| 37 | Arthropathy (HP:0003040) | 2.51871080 |
| 38 | Protruding tongue (HP:0010808) | 2.48753744 |
| 39 | Molar tooth sign on MRI (HP:0002419) | 2.44598343 |
| 40 | Abnormality of midbrain morphology (HP:0002418) | 2.44598343 |
| 41 | Pancreatic cysts (HP:0001737) | 2.43715945 |
| 42 | Abnormality of the fovea (HP:0000493) | 2.43392330 |
| 43 | Clumsiness (HP:0002312) | 2.42690932 |
| 44 | Large for gestational age (HP:0001520) | 2.41505003 |
| 45 | Poikiloderma (HP:0001029) | 2.39931730 |
| 46 | Gaze-evoked nystagmus (HP:0000640) | 2.36599086 |
| 47 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.35101801 |
| 48 | Pigmentary retinal degeneration (HP:0001146) | 2.34865253 |
| 49 | Gonadotropin excess (HP:0000837) | 2.33235381 |
| 50 | Abnormality of magnesium homeostasis (HP:0004921) | 2.32028101 |
| 51 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.26699074 |
| 52 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.25024576 |
| 53 | Drooling (HP:0002307) | 2.20213693 |
| 54 | Cerebellar dysplasia (HP:0007033) | 2.19204688 |
| 55 | True hermaphroditism (HP:0010459) | 2.19007747 |
| 56 | Dyschromatopsia (HP:0007641) | 2.18662155 |
| 57 | Nephronophthisis (HP:0000090) | 2.16756854 |
| 58 | Polydipsia (HP:0001959) | 2.16299427 |
| 59 | Abnormal drinking behavior (HP:0030082) | 2.16299427 |
| 60 | Long nose (HP:0003189) | 2.15491862 |
| 61 | Type II lissencephaly (HP:0007260) | 2.13470228 |
| 62 | Oligomenorrhea (HP:0000876) | 2.13304345 |
| 63 | Scotoma (HP:0000575) | 2.12297609 |
| 64 | Chorioretinal atrophy (HP:0000533) | 2.10034731 |
| 65 | Albinism (HP:0001022) | 2.08293726 |
| 66 | Tented upper lip vermilion (HP:0010804) | 2.03926506 |
| 67 | Lack of skin elasticity (HP:0100679) | 2.02084884 |
| 68 | Increased corneal curvature (HP:0100692) | 1.99915472 |
| 69 | Keratoconus (HP:0000563) | 1.99915472 |
| 70 | Excessive salivation (HP:0003781) | 1.99914438 |
| 71 | Abnormality of the aortic arch (HP:0012303) | 1.99442889 |
| 72 | Atonic seizures (HP:0010819) | 1.96909812 |
| 73 | Pancreatic fibrosis (HP:0100732) | 1.95261732 |
| 74 | Abnormal hair whorl (HP:0010721) | 1.95167719 |
| 75 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.94144191 |
| 76 | Abnormality of the nasal septum (HP:0000419) | 1.91949253 |
| 77 | Inability to walk (HP:0002540) | 1.91855307 |
| 78 | Medial flaring of the eyebrow (HP:0010747) | 1.91178022 |
| 79 | Generalized tonic-clonic seizures (HP:0002069) | 1.89418058 |
| 80 | Tachypnea (HP:0002789) | 1.88098529 |
| 81 | Gait imbalance (HP:0002141) | 1.87517688 |
| 82 | Poor head control (HP:0002421) | 1.87021078 |
| 83 | Abolished electroretinogram (ERG) (HP:0000550) | 1.86792224 |
| 84 | Abnormality of renin-angiotensin system (HP:0000847) | 1.84951482 |
| 85 | Increased circulating renin level (HP:0000848) | 1.84568668 |
| 86 | Constricted visual fields (HP:0001133) | 1.84490065 |
| 87 | Broad alveolar ridges (HP:0000187) | 1.83282913 |
| 88 | Vaginal atresia (HP:0000148) | 1.81498079 |
| 89 | Partial agenesis of the corpus callosum (HP:0001338) | 1.81193932 |
| 90 | Decreased circulating renin level (HP:0003351) | 1.80487350 |
| 91 | Status epilepticus (HP:0002133) | 1.79176338 |
| 92 | Congenital primary aphakia (HP:0007707) | 1.76833350 |
| 93 | Absence seizures (HP:0002121) | 1.76686830 |
| 94 | Ketoacidosis (HP:0001993) | 1.75843718 |
| 95 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.75767715 |
| 96 | Abnormality of the renal medulla (HP:0100957) | 1.74153635 |
| 97 | Tetany (HP:0001281) | 1.73558867 |
| 98 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.73316656 |
| 99 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.73098949 |
| 100 | Macroorchidism (HP:0000053) | 1.72420246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.89731857 |
| 2 | FRK | 4.83398409 |
| 3 | ADRBK2 | 4.64633190 |
| 4 | NME1 | 4.60640215 |
| 5 | ICK | 3.92184532 |
| 6 | STK38L | 3.28481393 |
| 7 | ACVR1B | 2.50437772 |
| 8 | PINK1 | 2.47548988 |
| 9 | WNK4 | 2.42643342 |
| 10 | INSRR | 2.38864806 |
| 11 | PLK4 | 2.05942677 |
| 12 | NEK6 | 2.02772010 |
| 13 | MAP4K2 | 1.94745641 |
| 14 | GRK1 | 1.82376821 |
| 15 | PLK2 | 1.79102822 |
| 16 | STK38 | 1.62442826 |
| 17 | MAP2K6 | 1.56449687 |
| 18 | STK39 | 1.54711440 |
| 19 | PRKCE | 1.42859132 |
| 20 | ERN1 | 1.39508451 |
| 21 | ZAK | 1.37368193 |
| 22 | PNCK | 1.35327550 |
| 23 | PRKD3 | 1.35159701 |
| 24 | MAP3K4 | 1.31199358 |
| 25 | DYRK3 | 1.28821264 |
| 26 | MAP2K2 | 1.25165902 |
| 27 | MAP2K7 | 1.21802399 |
| 28 | WNK1 | 1.19766518 |
| 29 | PDK2 | 1.18871746 |
| 30 | SIK2 | 1.10773040 |
| 31 | DAPK2 | 1.07653731 |
| 32 | MAP2K1 | 1.07267357 |
| 33 | CSNK1A1L | 1.06307760 |
| 34 | EIF2AK1 | 1.04670053 |
| 35 | MAP3K9 | 1.00468282 |
| 36 | PRKCG | 1.00287666 |
| 37 | ADRBK1 | 0.97829998 |
| 38 | IRAK1 | 0.95085219 |
| 39 | LATS2 | 0.94560771 |
| 40 | FER | 0.93511323 |
| 41 | MARK1 | 0.91691527 |
| 42 | BMPR1B | 0.90475622 |
| 43 | OXSR1 | 0.85688651 |
| 44 | LATS1 | 0.80971320 |
| 45 | PAK3 | 0.79568770 |
| 46 | PRKCH | 0.74020104 |
| 47 | TAOK3 | 0.70679012 |
| 48 | NTRK1 | 0.70620468 |
| 49 | CAMK1G | 0.69323612 |
| 50 | PIK3CG | 0.62048606 |
| 51 | PRKCI | 0.60342405 |
| 52 | MATK | 0.58900814 |
| 53 | PRKD2 | 0.57675312 |
| 54 | MAPK13 | 0.55116531 |
| 55 | PHKG1 | 0.51233921 |
| 56 | PHKG2 | 0.51233921 |
| 57 | MARK3 | 0.49091213 |
| 58 | STK3 | 0.47893781 |
| 59 | CAMK2A | 0.47491194 |
| 60 | NLK | 0.46921113 |
| 61 | EPHB1 | 0.45352981 |
| 62 | MUSK | 0.44376510 |
| 63 | CSNK1G2 | 0.42562609 |
| 64 | NTRK3 | 0.41606253 |
| 65 | HIPK2 | 0.40461149 |
| 66 | TGFBR1 | 0.39989389 |
| 67 | PDPK1 | 0.39850916 |
| 68 | MAPKAPK5 | 0.39243708 |
| 69 | EPHA3 | 0.36816133 |
| 70 | TLK1 | 0.36127031 |
| 71 | TNK2 | 0.35717180 |
| 72 | CAMK1 | 0.34469554 |
| 73 | KIT | 0.34066706 |
| 74 | SGK2 | 0.32170880 |
| 75 | MAP2K4 | 0.31907724 |
| 76 | SYK | 0.31511862 |
| 77 | STK24 | 0.31006090 |
| 78 | TXK | 0.30299651 |
| 79 | NEK9 | 0.29882849 |
| 80 | PRKAA2 | 0.29093982 |
| 81 | SGK1 | 0.28782455 |
| 82 | PRKACA | 0.28287948 |
| 83 | MAP3K2 | 0.27938994 |
| 84 | PRKCA | 0.27039595 |
| 85 | MAPKAPK3 | 0.26095320 |
| 86 | ATM | 0.25268673 |
| 87 | CHUK | 0.25010997 |
| 88 | ATR | 0.24926095 |
| 89 | PRKCB | 0.24695570 |
| 90 | CSNK1A1 | 0.24276191 |
| 91 | GRK5 | 0.24006681 |
| 92 | RPS6KA2 | 0.23618442 |
| 93 | ERBB2 | 0.23372177 |
| 94 | SGK223 | 0.23092052 |
| 95 | SGK494 | 0.23092052 |
| 96 | MELK | 0.22190301 |
| 97 | MAPK8 | 0.21967092 |
| 98 | IKBKB | 0.21188222 |
| 99 | AKT2 | 0.21072349 |
| 100 | PRKD1 | 0.20447946 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.12484412 |
| 2 | Phototransduction_Homo sapiens_hsa04744 | 3.09689953 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.09112732 |
| 4 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.01716085 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.80288433 |
| 6 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.35621853 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.28992488 |
| 8 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.19685721 |
| 9 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.16499964 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.11955730 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.08898312 |
| 12 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.07610983 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.00573069 |
| 14 | Taste transduction_Homo sapiens_hsa04742 | 1.99688698 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.97495860 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.88915597 |
| 17 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.87809793 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.81819547 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81376211 |
| 20 | ABC transporters_Homo sapiens_hsa02010 | 1.73158115 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72166778 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71915690 |
| 23 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.61012797 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.45281548 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42395131 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37064642 |
| 27 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.36827308 |
| 28 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30334368 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.28585364 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26425851 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.20307160 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.16617784 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16445912 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15971478 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12207896 |
| 36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.11050295 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09343431 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09261948 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.05756628 |
| 40 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03363008 |
| 41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01545893 |
| 42 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00003953 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95441191 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94249218 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 0.93877560 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.93510397 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93367009 |
| 48 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92592589 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.91571153 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90964538 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 0.90851120 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90791608 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.86640907 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84162125 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.83887981 |
| 56 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83614258 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83071920 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 0.82342780 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.78361636 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77333387 |
| 61 | Protein export_Homo sapiens_hsa03060 | 0.72587824 |
| 62 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71777832 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71488041 |
| 64 | Retinol metabolism_Homo sapiens_hsa00830 | 0.69458255 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.66939549 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.66359416 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.64710218 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61536356 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58677630 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58590869 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58552085 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57603512 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.57119054 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54624731 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.53184418 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52749886 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50254743 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50151046 |
| 79 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49631887 |
| 80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49589316 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49223229 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.47182689 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.46894475 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43366284 |
| 85 | RNA degradation_Homo sapiens_hsa03018 | 0.43218133 |
| 86 | Peroxisome_Homo sapiens_hsa04146 | 0.41038303 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.40752296 |
| 88 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.39632029 |
| 89 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39515530 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39429884 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.38077891 |
| 92 | Renin secretion_Homo sapiens_hsa04924 | 0.38047821 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.35886571 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.34946588 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33981410 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.31922767 |
| 97 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31115863 |
| 98 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30931675 |
| 99 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.26956300 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.24505571 |

